CJC-1295 + Ipamorelin: The Best GH Peptide Stack

CJC-1295 and Ipamorelin are the most commonly combined growth hormone peptides because they work through complementary mechanisms. CJC-1295 is a GHRH analog — it amplifies growth hormone pulses. Ipamorelin is a GHRP — it triggers the timing of those pulses. Together they produce a synergistic effect: the GH release from the combination is significantly greater than either peptide alone.

Think of it like a speaker system: Ipamorelin decides when to play the music (triggers the pulse), and CJC-1295 turns up the volume (amplifies the pulse). The result is a larger, more robust GH release that still follows the body's natural pulsatile pattern.

CJC-1295 (Modified GRF 1-29) is a synthetic version of growth hormone-releasing hormone with amino acid substitutions that extend its half-life to about 30 minutes. It binds to GHRH receptors on the pituitary gland and increases the amplitude of GH pulses. The no-DAC version is preferred because it preserves natural GH pulsatility.

Ipamorelin is a pentapeptide that binds to ghrelin receptors (GHS-R1a) on the pituitary, triggering GH release. Unlike older GHRPs such as GHRP-6 and GHRP-2, Ipamorelin is highly selective — it does not significantly raise cortisol, prolactin, or appetite, making it the cleanest GHRP available.

The most common protocol is:

100 mcg CJC-1295 (no DAC) + 200-300 mcg Ipamorelin, mixed in the same syringe, injected subcutaneously 2-3 times daily.

Timing matters. The three most effective injection windows are: upon waking (fasted), post-workout, and 30 minutes before bed. The pre-bed dose is considered the most important because it coincides with the body's natural nocturnal GH surge.

Avoid injecting within 30 minutes of eating. Elevated blood sugar and insulin blunt GH release significantly. Fat and carbohydrates are the worst offenders — protein has less impact.

Most protocols run 8-12 weeks on, followed by 4 weeks off to prevent pituitary desensitization. Some clinicians prescribe ongoing protocols with periodic breaks.

Week 1-2: Improved sleep quality is typically the first noticeable effect. Deeper sleep, more vivid dreams, and waking up feeling more rested.

Week 2-4: Recovery from exercise improves. Muscle soreness resolves faster. Skin may start to look fuller and more hydrated.

Week 4-8: Body composition changes become more apparent. Gradual fat loss (particularly visceral fat), improved muscle tone, and better overall energy levels.

Week 8-12: Cumulative effects on skin elasticity, hair quality, joint comfort, and body composition. Results are gradual and subtle compared to direct HGH — these peptides stimulate your own production rather than replacing it.

GH peptide effects are not dramatic or rapid. They work best as part of a consistent protocol alongside proper training, nutrition, and sleep.

The combination is generally well-tolerated. Common side effects include:

Injection site reactions: Mild redness, itching, or a small welt at the injection site. Usually resolves within 30 minutes. Rotating sites helps.

Water retention: Mild bloating or puffiness, particularly in the first 2 weeks. This typically subsides as the body adjusts.

Tingling or numbness: Carpal tunnel-like symptoms in the hands, especially at night. This indicates elevated GH levels and may require a dose reduction.

Head rush or flushing: A brief warm flush after injection, lasting a few minutes. More common with Ipamorelin.

Serious side effects are rare at standard doses. If tingling persists or joint pain develops, reduce the dose.

CJC-1295 comes in two versions. The no-DAC version (Modified GRF 1-29) has a ~30 minute half-life and is injected 2-3 times daily. The DAC version has a 6-8 day half-life and is injected once weekly.

The no-DAC version is strongly preferred for most protocols. It preserves the body's natural pulsatile GH rhythm — short bursts followed by troughs. The DAC version creates a sustained, elevated GH baseline that mimics constant GH infusion. This can lead to pituitary desensitization, disrupted sleep-related GH patterns, and potentially more side effects.

The only real advantage of DAC is convenience (weekly vs daily injections). For health and efficacy, no-DAC combined with Ipamorelin remains the gold standard.